We have updated our privacy policy. If you have any question, contact us at privacy@scicrunch.org. Dismiss and don't show again

Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

P63 alpha mutations lead to aberrant splicing of keratinocyte growth factor receptor in the Hay-Wells syndrome.

p63, a p53 family member, is required for craniofacial and limb development as well as proper skin differentiation. However, p63 mutations associated with the ankyloblepharon-ectodermal dysplasia-clefting (AEC) syndrome (Hay-Wells syndrome) were found in the p63 carboxyl-terminal region with a sterile alpha-motif. By two-hybrid screen we identified several proteins that interact with the p63alpha carboxyl terminus and its sterile alpha-motif, including the apobec-1-binding protein-1 (ABBP1). AEC-associated mutations completely abolished the physical interaction between ABBP1 and p63alpha. Moreover the physical association of p63alpha and ABBP1 led to a specific shift of FGFR-2 alternative splicing toward the K-SAM isoform essential for epithelial differentiation. We thus propose that a p63alpha-ABBP1 complex differentially regulates FGFR-2 expression by supporting alternative splicing of the K-SAM isoform of FGFR-2. The inability of mutated p63alpha to support this splicing likely leads to the inhibition of epithelial differentiation and, in turn, accounts for the AEC phenotype.

Pubmed ID: 12692135 RIS Download

Mesh terms: Abnormalities, Multiple | Animals | Cell Differentiation | DNA-Binding Proteins | Ectodermal Dysplasia | Epithelial Cells | Gene Expression Regulation | Genes, Tumor Suppressor | Heterogeneous-Nuclear Ribonucleoprotein Group A-B | Humans | Membrane Proteins | Mice | Mouth Abnormalities | Mutation | Phosphoproteins | Protein Binding | Protein Isoforms | Protein Splicing | RNA-Binding Proteins | Receptor, Fibroblast Growth Factor, Type 2 | Receptors, Fibroblast Growth Factor | Syndrome | Trans-Activators | Transcription Factors | Tumor Suppressor Proteins | Two-Hybrid System Techniques

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NIAID NIH HHS, Id: R01-AI47224
  • Agency: NIDCR NIH HHS, Id: R01-DE13561

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

We have not found any resources mentioned in this publication.